2-Bromo-3-Fluoro-4-Picoline | CAS:884494-37-5

We serve 2-Bromo-3-Fluoro-4-Picoline CAS:884494-37-5 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
2-Bromo-3-Fluoro-4-Picoline

Chemical Name: 2-Bromo-3-Fluoro-4-Picoline
CAS.NO:884494-37-5
Synonyms:2-bromo-3-fluoro-4-methylpyridine;
Molecular Formula: C6H5BrFN
Molecular Weight: 190.01300
 
Physical and Chemical Properties:
Density: 1.592g/cm3
Melting point: /
Boiling point: 203.9ºC at 760 mmHg
Flash point: 77.1ºC
Index of Refraction: 1.529
 
Specification:
Appearance: Colorless liquid
Purity:≥99.0%
 
Packing:25 KGS/Drum
Storage:Store in a tightly closed container. Store in a cool, dry
Application:   used in the Organic intermediate.



Contact us for information like 2-Bromo-3-Fluoro-4-Picoline chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2-bromo-3-fluoro-4-methylpyridine physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2-Bromo-3-Fluoro-4-Picoline Use and application,2-Bromo-3-Fluoro-4-Picoline technical grade,usp/ep/jp grade.


Related News: Active pharmaceutical ingredients directly impact disease.2,6-Bis[(2-Hydroxyethyl)Amino]Toluene manufacturer At the same time, experts said that API companies need to increase investment in environmental protection, carry out industrial upgrades, improve processes, improve pollution treatment capabilities, and then achieve sustainable development in the future, and seize structural opportunities.(S)-4-Methyloxazolidine-2,5-dione supplier In a stringent xenograft model of disseminated lymphoblastic leukemia, FT819 demonstrated enhanced tumor clearance and control of leukemia as compared to primary CAR19 T cells.2-Methylnaphthalene vendor China considers self-ruled Taiwan to be part of its territory and has long sought to limit its diplomatic relations and recognition at international bodies such as the W.H.O.Both patients were being treated in isolation units at a Manila hospital.